Description
Packing
10 vials of 5 ml.
Pharmacological action
Retinalamin is a complex of water-soluble polypeptide fractions with a molecular weight of not more than 10,000 Da.
Tissue repair stimulator. It has a stimulating effect on the photoreceptors and cellular elements of the retina, helps to improve the functional interaction of the pigment epithelium and the outer segments of the photoreceptors with dystrophic changes, accelerates the restoration of light sensitivity of the retina.
Normalizes vascular permeability, stimulates reparative processes in diseases and injuries of the retina.
The mechanism of action of Retinalamin ® is determined by its metabolic activity: the drug improves the metabolism of eye tissues and normalizes the functions of cell membranes, improves intracellular protein synthesis, regulates lipid peroxidation, contributes to the optimization of energy processes.
Pharmacokinetics
The composition of Retinalamin ®, the active substance of which is a complex of polypeptide fractions, does not allow the usual pharmacokinetic analysis of its individual components.
Indications
central or hereditary tapetoretinal abiotrophy
retinal pigment degeneration of various origins
diabetic retinopathy
secondary post-traumatic and post-inflammatory central retinal dystrophies.
Contraindications
Individual intolerance to the drug pregnancy.
Use during pregnancy and lactation
The drug is contraindicated in pregnancy. Perhaps the use of the drug during lactation according to indications.
Composition
1 vial contains:
Active ingredient:
retinalamine (a complex of water-soluble polypeptide fractions of the retina of livestock) 5 mg
Excipient:
glycine 17 mg.
Dosage and administration of
Adults
For diabetic retinopathy, central retinal dystrophy of inflammatory and traumatic genesis, central and peripheral tapetoretinal abiotrophy – parabulbar or IM 5 10 mg once a day. The course of treatment – 5-10 days, if necessary, repeat after 3-6 months.
With compensated primary open-angle glaucoma – parabulbar or IM 5 mg once a day. The course of treatment – 10 days, if necessary, repeat after 3-6 months.
In case of myopic disease – parabulbarly 5 mg once a day. The course of treatment is 10 days. It is recommended in combination with angioprotective agents and B vitamins.
The drug is dissolved in 1-2 ml of water for injection, 0.9% sodium chloride solution or 0.5% procaine solution (novocaine), directing the needle to the wall of the vial to avoid foaming.
For children aged 1 5 years
With central retinal dystrophy of inflammatory and traumatic origin, central and peripheral tapetoretinal abiotrophy – parabulbar or IM 2.5 mg once a day.
For children aged 6 18 years
With central retinal dystrophy of inflammatory and traumatic genesis, central and peripheral tapetoretinal abiotrophy – parabulbar or IM 2.5 5 mg once a day.
The drug is dissolved in 1-2 ml of 0.9% sodium chloride solution, directing the needle to the wall of the vial to avoid foaming. The course of treatment – 10 days, if necessary, repeat after 3-6 months.
Precautions for use. Retinalamin ® should be used only as directed by your doctor!
Dissolved drug vial cannot be stored and used after storage.
Retinalamin ® solution is not recommended to be mixed with other solutions.
Side effects
When used according to the indications in recommended doses, no side effect was detected.
Storage conditions
The drug should be stored in a dry, dark place, at a temperature of 2 ° to 20 ° C.
Expiration
2 years.
Terms of delivery from
pharmacies Prescription
Form of Treatment
simply entails dlya inaektsiy
